Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH)

BACKGROUND: Ertapenem (preferred choice for ESBL-producing organisms) use exhibited an increasing trend from 2006 to 2008. As extensive use of ertapenem might induce the mutation of resistant bacteria strains to ertapenem, we aimed to assess the appropriateness and impact of ertapenem-use, on ESBL p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Cheryl Li-Ling, Lee, Winnie, Lee, Amanda Ling-Chiu, Liew, Lisa Ting-Ting, Nah, Szu Chin, Wan, Choon Nam, Chlebicki, Maciej Piotr, Kwa, Andrea Lay-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879226/
https://www.ncbi.nlm.nih.gov/pubmed/24195651
http://dx.doi.org/10.1186/1471-2334-13-523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879226/
https://www.ncbi.nlm.nih.gov/pubmed/24195651
http://dx.doi.org/10.1186/1471-2334-13-523

Ejemplares similares